Lansen Pharmaceutical Holdings Ltd (503):企業の財務・戦略的SWOT分析

◆英語タイトル:Lansen Pharmaceutical Holdings Ltd (503) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH259076FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lansen Pharmaceutical Holdings Ltd (Lansen), a subsidiary of Cathay International Holdings Ltd is a pharmaceutical that develops, produces and sales specialty prescription western pharmaceuticals for the treatment of rheumatic diseases. The company’s products comprise specialist medicine, Chinese medicine generic drugs, IVD products, medical beauty products, healthy food and natural plant extracts. It provides other pharmaceutical products such as bazhen keli, dingpeng rugao and huperzine A capsules, among others. Lansen offers natural plant extracts of blackcurrant, bilberry, dicalcium, green tea, danshen, lutein, rhodiola rose, fleeceflower, panax ginsen and spine seeds, among others. The company’s products are used in treating rheumatic arthritis, osteoarthritis, and other diseases. Lansen is headquartered in Hong Kong.

This comprehensive SWOT profile of Lansen Pharmaceutical Holdings Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Lansen Pharmaceutical Holdings Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Lansen Pharmaceutical Holdings Ltd – Key Information
Lansen Pharmaceutical Holdings Ltd – Overview
Lansen Pharmaceutical Holdings Ltd – Key Employees
Lansen Pharmaceutical Holdings Ltd – Key Employee Biographies
Lansen Pharmaceutical Holdings Ltd – Key Operational Heads
Lansen Pharmaceutical Holdings Ltd – Major Products and Services
Lansen Pharmaceutical Holdings Ltd – History
Lansen Pharmaceutical Holdings Ltd – Company Statement
Lansen Pharmaceutical Holdings Ltd – Locations And Subsidiaries
Lansen Pharmaceutical Holdings Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Lansen Pharmaceutical Holdings Ltd – Business Description
Lansen Pharmaceutical Holdings Ltd – Corporate Strategy
Lansen Pharmaceutical Holdings Ltd – SWOT Analysis
SWOT Analysis – Overview
Lansen Pharmaceutical Holdings Ltd – Strengths
Lansen Pharmaceutical Holdings Ltd – Weaknesses
Lansen Pharmaceutical Holdings Ltd – Opportunities
Lansen Pharmaceutical Holdings Ltd – Threats
Lansen Pharmaceutical Holdings Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Lansen Pharmaceutical Holdings Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Lansen Pharmaceutical Holdings Ltd, Key Information
Lansen Pharmaceutical Holdings Ltd, Key Ratios
Lansen Pharmaceutical Holdings Ltd, Share Data
Lansen Pharmaceutical Holdings Ltd, Major Products and Services
Lansen Pharmaceutical Holdings Ltd, History
Lansen Pharmaceutical Holdings Ltd, Key Employees
Lansen Pharmaceutical Holdings Ltd, Key Employee Biographies
Lansen Pharmaceutical Holdings Ltd, Key Operational Heads
Lansen Pharmaceutical Holdings Ltd, Other Locations
Lansen Pharmaceutical Holdings Ltd, Subsidiaries
Lansen Pharmaceutical Holdings Ltd, Key Competitors
Lansen Pharmaceutical Holdings Ltd, SWOT Analysis
Lansen Pharmaceutical Holdings Ltd, Ratios based on current share price
Lansen Pharmaceutical Holdings Ltd, Annual Ratios
Lansen Pharmaceutical Holdings Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Lansen Pharmaceutical Holdings Ltd (503):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NicozDiamond Insurance Limited:企業の戦略・SWOT・財務情報
    NicozDiamond Insurance Limited - Strategy, SWOT and Corporate Finance Report Summary NicozDiamond Insurance Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • MeVis Medical Solutions AG (M3V):医療機器:M&Aディール及び事業提携情報
    Summary MeVis Medical Solutions AG (MMS AG), a subsidiary of Varian Medical Systems, Inc., is a medical technology company. It develops and markets software to analyze and evaluate image data to medical device equipment manufacturers and providers of medical IT platforms. The company’s software solu …
  • Braeburn Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Braeburn Pharmaceuticals Inc (Braeburn), a subsidiary of Apple Tree Partners is a pharmaceutical company that develops novel and long-acting implantable and injectable treatments.The company’s product pipeline includes Probuphine, CAM2038, BB-0417, BB-0817, BB-1216. Its Probuphine, is a a si …
  • European Investment Bank:企業の戦略的SWOT分析
    European Investment Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Leggett & Platt Incorporated:企業のM&A・事業提携・投資動向
    Leggett & Platt Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Leggett & Platt Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • CompuGroup Medical Deutschland AG (COP):医療機器:M&Aディール及び事業提携情報
    Summary CompuGroup Medical Deutschland AG (CGM) is a provider of medical software products and healthcare services. The company provides products such as communication solutions, software assisted medicine, dentist information systems, ambulatory information systems, drug safety and patient marketin …
  • Toppan Forms Co Ltd:企業の戦略・SWOT・財務分析
    Toppan Forms Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Toppan Forms Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Avient Corp (POL):企業の財務・戦略的SWOT分析
    Avient Corp (POL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • New Gold Inc:企業の戦略・SWOT・財務分析
    New Gold Inc - Strategy, SWOT and Corporate Finance Report Summary New Gold Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Cenovus Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Cenovus Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Cenovus Energy Inc (Cenovus Energy) is an integrated energy company, which explores, develops, produces and markets crude oil, natural gas liquids (NGLs) and natural gas. Cenovus Energy produces n …
  • Sumitomo Mitsui Trust Holdings Inc:企業の戦略・SWOT・財務情報
    Sumitomo Mitsui Trust Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Mitsui Trust Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Molson Coors Brewing Co (TAP):企業の財務・戦略的SWOT分析
    Molson Coors Brewing Co (TAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Biomunex Pharmaceuticals:製薬・医療:M&Aディール及び事業提携情報
    Summary Biomunex Pharmaceuticals (Biomunex) is a biopharmaceutical company that discovers and develops bispecific antibody therapeutics for the treatment of cancer. The company’s portfolio of pipeline products incldes BMX-101, which is developed as a novel immunotherapeutic treatment for relapsed an …
  • Tesla, Inc (TSLA):電力:M&Aディール及び事業提携情報
    Summary Tesla, Inc. (Tesla), formerly Tesla Motors, Inc., is an automotive and vertically integrated sustainable energy company. It designs, develops, manufactures and sells electric vehicles and energy storage products. The company also installs and maintains electric vehicles and energy storage sy …
  • NanoString Technologies Inc (NSTG):企業の財務・戦略的SWOT分析
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company offers products such as sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion …
  • Mylan NV (MYL)-製薬・医療分野:企業M&A・提携分析
    Summary Mylan NV (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics and branded medicines and consumer healthcare products. It offers pharmaceutical products in multiple forms across therapeutic categories such as respiratory and allergy, ca …
  • Medtronic PLC:企業の戦略・SWOT・財務情報
    Medtronic PLC - Strategy, SWOT and Corporate Finance Report Summary Medtronic PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Synthetic Biologics Inc (SYN):企業の財務・戦略的SWOT分析
    Summary Synthetic Biologics Inc (Synthetic Biologics), formerly Adeona Pharmaceuticals Inc is a clinical company that develops novel therapeutics to treat gut microbiome. The company’s pipeline products include SYN-004 and SYN-010. Its SYN-010 is a proprietary, modified-release formulation which is …
  • Arrogene Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Arrogene Inc (Arrogene) is a developer of cancer therapeutics and imaging products. The company develops nanomedicine products for the treatment of primary brain, lung, and triple negative breast cancer, and HER2-positive breast cancer and its metastasis. It offers cancer treatment technolog …
  • Dogus Otomotiv Servis ve Ticaret AS:戦略・SWOT・企業財務分析
    Dogus Otomotiv Servis ve Ticaret AS - Strategy, SWOT and Corporate Finance Report Summary Dogus Otomotiv Servis ve Ticaret AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆